Global Pulmonary Drug Delivery Systems Market 2012-2016

Global Pulmonary Drug Delivery Systems Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market. 
TechNavio's report, the Global Pulmonary Drug Delivery Systems Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Pulmonary Drug Delivery Systems market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space 3M Healthcare Ltd., AstraZeneca plc, GlaxoSmithKline plc, and Sunovion Pharmaceuticals Inc. 
The other vendors mentioned in this report are Akela Pharma Inc., Alkermes Inc., Allied Healthcare Products Inc., Boehringer Ingelheim GmbH, CareFusion Corp., Chiesi Farmaceutici S.p.A., Dainippon Sumitomo Pharma Co. Ltd., GF Health Products Inc., Novartis AG, PARI Respiratory Equipment Inc., Philips Respironics Inc., Omron Healthcare Co. Ltd., SkyePharma plc, and Vectura Group plc.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Market Size and Forecast

Market Segmentation

06.2 Global MDI Market

Market Size and Forecast

06.3 Global DPI Market

Market Size and Forecast

06.4 Global Nebulizer Market

Market Size and Forecast

06.5 Five Forces Analysis

07. Geographical Segmentation

08. Rate of Incidence and Prevalence

09. Vendor Landscape


Product Portfolio Matrix

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis


16.1 AstraZeneca plc

Business Overview

Key Information

SWOT Analysis

GlaxoSmithKline plc

Business Overview

Key Information

SWOT Analysis

16.2 Sunovion Pharmaceuticals Inc.

Business Overview

Key Information

SWOT Analysis

16.3 3M Healthcare Ltd.

Business Overview

Key Information

SWOT Analysis

17. Other Reports in this Series

List of Exhibits:


Exhibit 1: Market Research Methodology

Exhibit 2: Global Pulmonary Drug Delivery Systems Market 2012-2016 (US$ billion)

Exhibit 3: Global Pulmonary Drug Delivery Systems Market Segmentation

Exhibit 4: Global Pulmonary Drug Delivery Systems Market Segmentation 2012

Exhibit 5: Global Metered Dose Inhalers Market 2012-2016 (US$ billion)

Exhibit 6: Global Dry Powder Inhalers Market 2012-2016 (US$ billion)

Exhibit 7: Global Nebulizer Market 2012-2016 (US$ million)

Exhibit 8: Global Pulmonary Drug Delivery Systems Market by Geographical Segmentation 2012

Exhibit 9: Business Segmentation of GlaxoSmithKline plc

Exhibit 10: Business Segmentation of Sunovion Pharmaceuticals Inc


Enquiry Before Buy